COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,399 Articles (22,816 medRxiv, 8,583 bioRxiv)

Most recent first Previous |  Page 1340: Articles 13391-13400  | Next

Llamanade: an open-source computational pipeline for robust nanobody humanization
Sang, Z., Xiang, Y., Bahar, I., Shi, Y.
10.1101/2021.08.03.455003 — Posted: 2021-08-04
Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database
Zelenova, M., Ivanova, A., Semyonov, S., Gankin, Y.
10.1101/2021.08.04.454929 — Posted: 2021-08-04
Contribution of single mutations to selected SARS-CoV-2 emerging variants Spike antigenicity
Gong, S. Y., Chatterjee, D., Richard, J., Prevost, J., Tauzin, A., Gasser, R., Bo, Y., Vezina, D., Goyette, G., Gendron-Lepage, G., Medjahed, H., Roger, M., Cote, M., Finzi, A.
10.1101/2021.08.04.455140 — Posted: 2021-08-04
GlycoSHIELD: a versatile pipeline to assess glycan impact on protein structures
Gecht, M., von Bülow, S., Penet, C., Hummer, G., Hanus, C., Sikora, M.
10.1101/2021.08.04.455134 — Posted: 2021-08-04
Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity
Koide, A., Panchenko, T., Wang, C., Thannickal, S. A., Romero, L. A., Teng, K. W., Li, F.-Z., Akkapeddi, P., Corrado, A. D., Caro, J., Diefenbach, C., Samanovic, M. I., Mulligan, M. J., Hattori, T., Stapleford, K. A., Li, H. J., Koide, S.
10.1101/2021.08.03.454782 — Posted: 2021-08-04
A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
Wang, J. Y., Roehrl, M. W., Roehrl, V. B., Roehrl, M. H.
10.1101/2021.07.30.454526 — Posted: 2021-08-04
Azithromycin in patients with Covid-19; a systematic review and metanalysis
Ayerbe, L., Forgnone, I., Risco-Risco, C., Perez-Pinar, M., Ayis, S.
10.1101/2021.08.03.21261414 — Posted: 2021-08-04
A single intramuscular injection of monoclonal antibody MAD0004J08 induces in healthy adults SARS-CoV-2 neutralising antibody titres exceeding those induced by infection and vaccination
Lanini, S., Milleri, S., Andreano, E., Nosari, S., Paciello, I., Piccini, G., Gentili, A., Phogat, A., Hyseni, I., Leonardi, M., Torelli, A., Montomoli, E., Paolini, A., Frosini, A., Antinori, A., Nicastri, E., Girardi, E., Plazzi, M. M., Ippolito, G., Vaia, F., Della Cioppa, G., Rappuoli, R.
10.1101/2021.08.03.21261441 — Posted: 2021-08-04
Prospective cohort study of socioeconomic status and subsequent unemployment under COVID-19 in Japan
Kuroishi, M., Nagata, T., Hino, A., Tateishi, S., Ogami, A., Tsuji, M., Matsuda, S., Fujino, Y., Mori, K.
10.1101/2021.08.03.21261518 — Posted: 2021-08-04
Domestic and international mobility trends in the United Kingdom during the COVID-19 pandemic: An analysis of Facebook data
Shepherd, H. E. R., Atherden, F. S., Chan, H. M. T., Loveridge, A., Tatem, A. J.
10.1101/2021.08.03.21261545 — Posted: 2021-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).